2010-2015: Fourth Military Medical University, Clinical medicine, Bachelor's degree; 2015-2021: Air-Force Medical University, Immunology, Doctorate degree; 2021-present: Air-Force Medical University, Department of Immunology, Lecturer. Dr. Dongbo Jiang serves as a college mentor and investigator at the Department of Immunology, Basic Medical School of Air Force Medical University, China. He is also a key member of the Bio-hazard Prevention and Treatment Drug Key Laboratory of the PLA. Dr. Jiang earned his Ph.D. in Immunology and has since focused his research on cellular and molecular immunology, viral hemorrhagic fever vaccines, tumor systems biology, and cancer immunotherapy. His work integrates multi-omics approaches with machine learning to uncover immunologic regulators in diseases such as viral infection, inflammatory disorders, and neoplasms. He has authored multiple high-impact publications, including studies on nucleic acids or epitope-based vaccines and immune-inflammatory biomarkers in oncology. Dr. Jiang is actively involved in antiviral vaccine development and translational oncology research, with a strong commitment to advancing precision immunotherapy and biomarker-driven clinical applications. Research Keywords: Tumor immunology, Cancer immunotherapy, Viral hemorrhagic fever vaccines, Pan MHC I/II epitopes, Multi-omics integration, Computational immunology, Systemic immune-inflammation, Biomarker discovery, Tumor microenvironment, Translational oncology